Table 1 Number of patients in whom at least one MSA/MAA was positive (patients with several positive antibodies not excluded). MSA: myositis-specific antibodies, MAA: myositis-associated antibodies
Positive determined antibody | Number of patients in the antibody-groups, n (%) |
|---|---|
MSA | |
EJ | 4 (1.7) |
PL7 | 24 (10.2) |
OJ | 7 (3.0) |
PL12 | 12 (5.1) |
Mi-2 | 13 (5.5) |
TIF1γ | 13 (5.5) |
MDA5 | 5 (2.1) |
SAE | 7 (3.0) |
NXP2 | 11 (4.7) |
SRP | 10 (4.2) |
MAA | |
Ku | 41 (17.4) |
PM-Scl100 | 44 (18.6) |
PM-Scl75 | 45 (19.1) |